Feature Selection and Network‐Driven Analyses to Unveil Common RNA Signatures in Colon and Pancreatic KRAS‐Mutant Cancers
ABSTRACT Background Colon cancer and pancreatic ductal adenocarcinoma are among the most aggressive tumors for which therapeutic options are limited. Both cancers share common features, such as some KRAS pathogenic variants and common epidemiology. The integration of multidimensional datasets by com...
Saved in:
| Main Authors: | Katia Pane, Mario Zanfardino, Anna Maria Grimaldi, Ilaria Leone, Silvia Nuzzo, Marco Salvatore, Monica Franzese |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70468 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
by: Satoru Miyazaki, et al.
Published: (2025-02-01) -
Gold nanoparticle resveratrol complex increases apoptosis in KRAS mutant pancreatic cancer cells
by: Seung Myun Hong, et al.
Published: (2025-04-01) -
Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
by: Nawaz Khan, et al.
Published: (2025-07-01) -
L-Ascorbic acid preferentially kills KRAS mutant pancreatic cancer cells through DNA damage
by: Hye-Lim Jang, et al.
Published: (2025-07-01) -
Elevated KRAS protein level is associated with better survival in pancreatic cancer
by: S. M. Stålberg, et al.
Published: (2025-07-01)